Canaccord Genuity on Biotechnology: 2012 Best Ideas - Aegerion (AEGR), Anthera (ANTH): A Year of Transformative, Yet Derisked Late-Stage Binary Catalysts
Go back to Canaccord Genuity on Biotechnology: 2012 Best Ideas - Aegerion (AEGR), Anthera (ANTH): A Year of Transformative, Yet Derisked Late-Stage Binary Catalysts| AEGERION PHARMA (NASDAQ: AEGR) | Delayed: 1.97 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.97 | 52 Week High | $10.85 | |||
| Open | $0.00 | 52 Week Low | $1.23 | |||
| Day High | $1.97 | P/E | N/A | |||
| Day Low | $1.97 | EPS | $-2.60 | |||
| Volume | 61,814 | |||||
| ANTHERA PHARMA (AMEX: ANTH) | Delayed: 0.00 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.00 | 52 Week High | $6.08 | |||
| Open | $0.00 | 52 Week Low | $1.72 | |||
| Day High | $0.00 | P/E | 0.00 | |||
| Day Low | $0.00 | EPS | $-1.47 | |||
| Volume | 688,397 | |||||
